| TRADING CENTER |
| Biotech Stock Mailbag: Soligenix - at TheStreet.com | |
| Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes - Business Wire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.21 | -0.25 / -0.44% | 11.65 |
| GILD | Gilead Sciences Inc | 46.30 | 0.21 / 0.46% | 15.13 |
| CELG | Celgene Corporation | 55.50 | 0.73 / 1.33% | 26.68 |
| 2008 Revenue: | $10.0 M | Headquarters: Columbia, MD |
| Employees: | 163 | CEO: Dr. C. Randal Mills, Ph.D. |
| Net Income: | $-33,492,000.0 | Industry: Biotechnology |
| Market Cap: | $283.5 M | Website: www.osiristx.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| OSIR | 8.65 | +0.12 / +1.41% | 8.53 | 8.69 | 8.55 | Profile Chart News |